Skip to main content
. 2012 Sep 17;30(31):3792–3799. doi: 10.1200/JCO.2011.40.0010

Fig 2.

Fig 2.

Cumulative incidence of cardiac events in National Surgical Adjuvant Breast and Bowel Project B-31. ACP, doxorubicin, cyclophosphamide, and paclitaxel; ACPH, doxorubicin, cyclophosphamide, paclitaxel, and trastuzumab; HR, hazard ratio.